| Drug ID: | Drug59 |
|---|---|
| Drug Name: | Sodium Picosulfate |
| CID: | 68654 |
| DrugBank ID: | NULL |
| Modality: | Small Molecule |
| Groups: | NULL |
| US Approved: | NULL |
| Other Approved: | NULL |
| Identifier: | NCT05684484 |
| Molecular Formula: | C18H13NNa2O8S2 |
| Molecular Weight: | 481.4 g/mol |
| Isomeric SMILES: | C1=CC=NC(=C1)C(C2=CC=C(C=C2)OS(=O)(=O)[O-])C3=CC=C(C=C3)OS(=O)(=O)[O-].[Na+].[Na+] |
| Synonyms: | sodium picosulfate; 10040-45-6; Picosulfate sodium; Neopax; Sodium picosulphate; Evacuol; Guttalax; Rapilax; Laxidogol; Evanol |
| Phase 0: | 0 |
| Phase 1: | 0 |
| Phase 2: | 0 |
| Phase 3: | 0 |
| Phase 4: | 0 |
| Description: | NULL |
Molecular Structure
Knowledge Graph
| dtID | CID | Compound Name | Gene ID | Gene Name | Species | PubMed IDs | Action |
|---|---|---|---|---|---|---|---|
| No data available | |||||||
- No data available
Phase Distribution
Phase Description
- Phase 0: Exploratory trials to assess drug behavior in humans
- Phase 1: Safety trials to determine safe dosage range
- Phase 2: Efficacy trials to evaluate therapeutic effects
- Phase 3: Large-scale trials to confirm efficacy and safety
- Phase 4: Post-marketing surveillance for long-term safety and efficacy
| Trial ID | Title | Phase | Status | Sponsor | Indications | Interventions | |
|---|---|---|---|---|---|---|---|
| NCT03593252 | Bowel Preparation in Elective Pediatric Colorectal Surgery | NA | UNKNOWN | McMaster University | Colostomy|Hirschsprung Disease - Pull Through|Nec… | DRUG: Senna|DRUG: Sodium Picosulfate, Magnesium O… | Details |
| NCT03581149 | Tolerability and Efficacy of Sodium Picosulfate/Magnesium Citrate Versus PEG/Ascorbic Acid in Ulcerative Colitis Patients | PHASE4 | UNKNOWN | American University of Beirut Medical Center | Ulcerative Colitis | DRUG: Sodium Picosulfate/Magnesium Citrate Laxati… | Details |
| JPRN-UMIN000046015 | A prospective, controlled, randomized, assessor-blind, comparative study of a new oral bowel cleanser (Sodium Picosulfate/Magnesium Citrate) versus existing oral bowel cleanser (Magnesium Citrate) in pediatric colonoscopy preparation. - A prospective, con | NULL | Not Recruiting | Saitama children's Medical Center Division of Gastroenterology and Hepatology | Inflammatory bowel disease, Functional gastrointe… | PICOPREP MAGCOROL Powder | Details |
| ChiCTR2200056969 | Efficacy, tolerability and safety of Sodium picosulphate/magnesium citrate versus 3-L polyethylene glycol for bowel preparation for patients with Inflammatory Bowel Disease | NULL | Recruiting | Shenzhen Hospital of Southern Medical University | Bowel preparation | Experimental group:intake sodium picosulfate/magn… | Details |
| NCT05726097 | Bowel Preparation Regimen for Colon Capsule Endoscopy Procedure | PHASE3 | COMPLETED | Region Skane | Colon Cancer|Inflammatory Bowel Diseases|Gastroin… | DRUG: polyethylene glycol|DRUG: sodium phosphate|… | Details |
| Disease ID | Disease Name | Definition | Category | Related Drugs | Mechanism | |
|---|---|---|---|---|---|---|
| No data available | ||||||
| Strategy ID | Therapeutic Strategy | Synonyms | Related Drugs | Mechanism | |
|---|---|---|---|---|---|
| No data available | |||||
No related literature
You can run management commands to establish drug-literature associations